ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
6,040.53
-0.50%
US Tech 100
20,778.00
-0.69%
다우존스 지수
44,544.66
-0.75%
Bitcoin
99,129.07
-1.53%
Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ

  6. Kronos Bio Inc (KRON) 시세

Kronos Bio Inc

Kronos Bio Inc (KRON)

Kronos Strategy
1.01
-0.025
(-2.42%)
마감 03 2월 6:00AM
15분 지연
0.9901
-0.0199
(-1.97%)
시간외 거래: 9:59AM
15분 지연

포트폴리오 강화: 실시간 토론 및 실행 가능한 거래 아이디어.

프리미엄

주요 통계 및 세부정보

가격
1.01
매수가
0.95
매도가
1.07
거래량
144,355
0.995 일간 변동폭 1.04
0.69 52주 범위 1.60
market_cap
60.944M
전일 종가
1.035
개장가
1.04
최근 거래 시간
1
@
0.99
마지막 거래 시간
재정 규모
US$ 144,905
VWAP
1.0038
평균 볼륨(3m)
321,711
발행 주식
60,340,918
배당수익률
-
주가수익률
-0.54
주당순이익(EPS)
-1.87
매출
6.29M
순이익
-112.67M

Kronos Bio Inc 정보

Kronos Bio Inc is a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel cancer therapeutics designed to transform patient outcomes through a precision medicine strategy by targeting dysregulated transcription. Kronos Bio Inc is a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel cancer therapeutics designed to transform patient outcomes through a precision medicine strategy by targeting dysregulated transcription.

섹터
Pharmaceutical Preparations
산업
Pharmaceutical Preparations
웹사이트
www.kronosbio.com
본부
Wilmington, Delaware, USA
설립됨
-
Kronos Bio Inc is listed in the Pharmaceutical Preparations sector of the 나스닥 with ticker KRON. The last closing price for Kronos Bio was US$1.04. Over the last year, Kronos Bio shares have traded in a share price range of US$ 0.69 to US$ 1.60.

Kronos Bio currently has 60,340,918 shares in issue. The market capitalisation of Kronos Bio is US$62.45 million. Kronos Bio has a price to earnings ratio (PE ratio) of -0.54.

KRON 최신 뉴스

추가 뉴스

Kronos Bio Announces CEO Transition and Reduction in Force

– Norbert Bischofberger, Ph.D., is stepping down from his role as President & CEO – – Deborah Knobelman, Ph.D., COO & CFO, is named President & Interim CEO – SAN MATEO, Calif. and...

27 11월 2024
GlobeNewswire Inc.

Form EFFECT - Notice of Effectiveness

15 11월 2024
Edgar (US Regulatory)

Kronos Bio Highlights Preclinical Data that Show p300 KAT Inhibitors Reduce Inflammation in an Oral Presentation at ACR Convergence 2024

– Preclinical data demonstrate the ability of p300 KAT inhibition to modulate multiple pro-inflammatory signaling pathways, including antibodies and cytokine production, in ex vivo and in vivo...

15 11월 2024
GlobeNewswire Inc.

Form 8-K - Current report

14 11월 2024
Edgar (US Regulatory)

Kronos Bio Reports Third Quarter 2024 Financial Results and Corporate Update Including Plan to Evaluate Strategic Alternatives

– Discontinuing development of istisociclib, a CDK9 inhibitor; benefit-risk profile in platinum-resistant high-grade serous ovarian cancer does not support further development – – Kronos Bio...

14 11월 2024
GlobeNewswire Inc.

Form S-3 - Registration statement under Securities Act of 1933

08 11월 2024
Edgar (US Regulatory)

Kronos Bio to Present Data at the ASH Annual Meeting from p300 KAT Inhibition Program in Multiple Myeloma

– Data demonstrates Kronos Bio's approach to targeting oncogenic transcription factors and the strong relationship between IRF4 and p300 in Multiple Myeloma – – Poster presentation to take place...

05 11월 2024
GlobeNewswire Inc.

Kronos Bio Data Presentation at EORTC-NCI-AACR Symposium Highlights the Importance of p300 KAT Inhibition in HPV-Driven Tumors

SAN MATEO, Calif., and CAMBRIDGE, Mass., Oct. 23, 2024 (GLOBE NEWSWIRE) -- Kronos Bio, Inc. (Nasdaq: KRON), a company dedicated to developing small molecule therapeutics that address cancers and...

23 10월 2024
GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities

16 10월 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

16 10월 2024
Edgar (US Regulatory)
기간변동변동 %시가고가저가평균 일일 거래량VWAP
1-0.05-4.716981132081.061.070.98852415481.02898225CS
40.03013.071742014490.97991.070.91652110490.99889041CS
120.139716.0519361140.87031.090.83217110.94759519CS
26-0.27-21.093751.281.40.81872610.96121236CS
52-0.11-9.821428571431.121.60.692912431.03571664CS
156-8.12-88.93756845569.139.40.692953322.37213348CS
260-27.28-96.429833863628.2939.6050.692807568.05600164CS

KRON - Frequently Asked Questions (FAQ)

What is the current Kronos Bio share price?
The current share price of Kronos Bio is US$ 1.01
How many Kronos Bio shares are in issue?
Kronos Bio has 60,340,918 shares in issue
What is the market cap of Kronos Bio?
The market capitalisation of Kronos Bio is USD 62.45M
What is the 1 year trading range for Kronos Bio share price?
Kronos Bio has traded in the range of US$ 0.69 to US$ 1.60 during the past year
What is the PE ratio of Kronos Bio?
The price to earnings ratio of Kronos Bio is -0.54
What is the cash to sales ratio of Kronos Bio?
The cash to sales ratio of Kronos Bio is 9.69
What is the reporting currency for Kronos Bio?
Kronos Bio reports financial results in USD
What is the latest annual turnover for Kronos Bio?
The latest annual turnover of Kronos Bio is USD 6.29M
What is the latest annual profit for Kronos Bio?
The latest annual profit of Kronos Bio is USD -112.67M
What is the registered address of Kronos Bio?
The registered address for Kronos Bio is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808
What is the Kronos Bio website address?
The website address for Kronos Bio is www.kronosbio.com
Which industry sector does Kronos Bio operate in?
Kronos Bio operates in the PHARMACEUTICAL PREPARATIONS sector

이동자

모두 보기
  • 가장 활성
  • % 상승자
  • % 패자
기호가격볼륨
TCTMTCTM Kids IT Education Inc
US$ 0.764
(321.87%)
729.72M
REBNReborn Coffee Inc
US$ 3.31
(63.05%)
55.54M
FCUVFocus Universal Inc
US$ 5.87
(56.62%)
1.73M
SOPASociety Pass Inc
US$ 1.54
(56.50%)
13.82M
CYCNCyclerion Therapeutics Inc
US$ 3.92
(54.33%)
82.39M
ENVBEnveric Biosciences Inc
US$ 2.0899
(-46.41%)
1.57M
NIVFNewGenIvf Group Ltd
US$ 0.1489
(-42.51%)
14.8M
GLSTGlobal Star Acquisition Inc
US$ 8.83
(-39.10%)
23.89k
PRPHProPhase Labs Inc
US$ 0.2633
(-38.02%)
872.46k
SPGCSacks Parente Golf Inc
US$ 0.5601
(-37.86%)
7.27M
TCTMTCTM Kids IT Education Inc
US$ 0.764
(321.87%)
729.72M
NVDANVIDIA Corporation
US$ 120.07
(-3.67%)
388.54M
RIMEAlgorhythm Holdings Inc
US$ 0.02565
(5.12%)
338.75M
BHATBlue Hat Interactive Entertainment Technology
US$ 0.0355
(-11.25%)
236.29M
CLEUChina Liberal Education Holdings Ltd
US$ 0.1938
(30.77%)
234.8M

KRON Discussion

게시물 보기
PonkenPlonken PonkenPlonken 4 주 전
soon
👍️0
Monksdream Monksdream 5 월 전
KRON under $2
👍️0
Monksdream Monksdream 6 월 전
KRON under $2
👍️0
PonkenPlonken PonkenPlonken 7 월 전
Check CEO CV, super smart man that helped build Gilead before moving on to work on KRON. Recently he bought 8 million shares of common stock. I think its time to listen to whats being said. Chart sees clean breakout.

Probably the only promising CDK9 out there
👍️0
glenn1919 glenn1919 7 월 전
KRON.................................https://stockcharts.com/h-sc/ui?s=KRON&p=W&b=5&g=0&id=p86431144783
👍️0
Monksdream Monksdream 7 월 전
KRON under $2
👍️0
glenn1919 glenn1919 10 월 전
KRON.................................https://stockcharts.com/h-sc/ui?s=KRON&p=W&b=5&g=0&id=p86431144783
👍️0
Monksdream Monksdream 10 월 전
KRON under $2
👍️0
glenn1919 glenn1919 11 월 전
KRON....................................https://stockcharts.com/h-sc/ui?s=KRON&p=W&b=5&g=0&id=p86431144783
👍️0
Monksdream Monksdream 11 월 전
KRON under $2
👍️0
Monksdream Monksdream 1 년 전
KRON new 52 week low
👍️0
Monksdream Monksdream 1 년 전
KRON new 52 week low
👍️0

최근 히스토리

NASDAQ
KRON
Kronos Bio
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2025 ADVFN PLC - 모든 권리 보유

광고 제거

광고 없는 경험을 위해 가입하세요

광고 없음

지금 사용해 보세요

광고 유지